BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21804524)

  • 1. Role of VIA in cervical cancer screening in low-resource countries.
    Nahar KN; Nessa A; Shamim S; Nasrin B; Hossain F; Begum N
    Mymensingh Med J; 2011 Jul; 20(3):528-35. PubMed ID: 21804524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
    Ivanov S
    Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Perspective of cervical cancer prevention and control in developing countries and areas].
    Qiao YL
    Chin J Cancer; 2010 Jan; 29(1):1-3. PubMed ID: 20038301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
    Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
    Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of visual inspection of the cervix using acetic acid in cervical cancer screening: a comparison with cervical cytology.
    Akinola OI; Fabamwo AO; Oshodi YA; Banjo AA; Odusanya O; Gbadegesin A; Tayo A
    J Obstet Gynaecol; 2007 Oct; 27(7):703-5. PubMed ID: 17999297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of human papilloma virus-DNA test verses colposcopy as secondary cervical cancer screening test to triage screen positive women on primary screening by visual inspection with 5% acetic acid.
    Pimple S; Shastri SS
    Indian J Cancer; 2014; 51(2):117-23. PubMed ID: 25104191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of cervical cancer in HIV-seropositive women from developing countries through cervical cancer screening: a systematic review.
    Mapanga W; Girdler-Brown B; Feresu SA; Chipato T; Singh E
    Syst Rev; 2018 Nov; 7(1):198. PubMed ID: 30447695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer in developing countries: effective screening and preventive strategies with an application in Rwanda.
    Mukakalisa I; Bindler R; Allen C; Dotson J
    Health Care Women Int; 2014; 35(7-9):1065-80. PubMed ID: 24750113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening programs in low-income communities. Experiences from Ecuador. Low cost detection of HPV infection in a developing country.
    Cecchini G; Paganini G; D'Amico M; Cannone M; Bertuletti C; Barberis MC
    Pathologica; 2009 Apr; 101(2):76-9. PubMed ID: 19886552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of visual inspection of cervix and Pap smear for cervical cancer screening.
    Tayyeb R; Khawaja NP; Malik N
    J Coll Physicians Surg Pak; 2003 Apr; 13(4):201-3. PubMed ID: 12718787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
    Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
    J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi.
    Cubie HA; Campbell C
    Womens Health (Lond); 2020; 16():1745506520914804. PubMed ID: 32364058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of cervical-cancer screening in five developing countries.
    Goldie SJ; Gaffikin L; Goldhaber-Fiebert JD; Gordillo-Tobar A; Levin C; Mahé C; Wright TC;
    N Engl J Med; 2005 Nov; 353(20):2158-68. PubMed ID: 16291985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors.
    Sankaranarayanan R; Wesley R; Somanathan T; Dhakad N; Shyamalakumary B; Amma NS; Parkin DM; Nair MK
    Cancer; 1998 Nov; 83(10):2150-6. PubMed ID: 9827719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical screening strategies in resourced and resource-constrained countries.
    Cronjé HS
    Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):575-84. PubMed ID: 21689987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of cervical cancer through acetic acid application--an aided visual inspection.
    Singh V; Sehgal A; Parashari A; Sodhani P; Satyanarayana L
    Singapore Med J; 2001 Aug; 42(8):351-4. PubMed ID: 11764051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
    Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
    Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.